Evidio Domingo Musibay

Phase Ib: Preliminary clinical activity and immune activation for NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] in patients (pts) with locally advanced or metastatic solid tumors (REVEAL Phase Ib/II Trial).

J. Brugarolas, F. Cattaruzza, J. Zalevsky, 2019, Journal of Clinical Oncology.

Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients with advanced melanoma progressed on multiple prior therapies.

J. Larkin, J. Kirkwood, H. Kluger, 2020 .